NEW YORK, May 20, 2025 /PRNewswire/ -- ProCap Acquisition Corp (the "Company") announced today the pricing of its upsized initial public offering of 22,000,000 units at a price of $10.00 per unit. The units are expected to be listed on The Nasdaq Stock Market LLC ("Nasdaq") and begin trading tomorrow, May 21, 2025, under the ticker symbol "PCAPU." Each unit consists of one Class A ordinary share and one-third of one redeemable warrant, with each whole warrant entitling the holder thereof to purchase one Cla ...

Company Overview - Columbus Circle Capital Corp. I is a blank check company formed to effect mergers, amalgamations, share exchanges, asset acquisitions, share purchases, reorganizations, or similar business combinations with one or more businesses [7] - The management team includes Gary Quin as CEO and Chairman, and Joseph W. Pooler, Jr. as CFO, along with independent directors Garrett Curran, Alberto Alsina Gonzalez, Dr. Adam Back, and Matthew Murphy [7] Initial Public Offering (IPO) Details - The company closed its upsized initial public offering of 25,000,000 units, with gross proceeds of $250,000,000, priced at $10.00 per unit [1] - The offering included 3,000,000 units from the partial exercise of the underwriters' overallotment option [1] - Units began trading on NASDAQ under the ticker symbol "CCCMU" on May 16, 2025, with each unit consisting of one Class A ordinary share and one-half of one redeemable warrant [2] Financial and Legal Aspects - The proceeds from the IPO and a simultaneous private placement were placed in the company's trust account for the benefit of public shareholders [6] - The registration statement for the offering was declared effective by the SEC on May 15, 2025 [4] - Legal counsel for the company included Ellenoff Grossman & Schole LLP and Ogier (Cayman) LLP, while Loeb & Loeb LLP served as legal counsel to the underwriters [3] Cohen & Company Overview - Cohen & Company Inc. is a financial services company specializing in capital markets and asset management services [8] - The company operates through segments including Capital Markets, Asset Management, and Principal Investing, with a focus on mergers and acquisitions, capital markets, and SPAC advisory services [8] - As of March 31, 2025, Cohen & Company had approximately $2.3 billion in assets under management, primarily in fixed income assets [9]

Hong Kong, May 16, 2025 (GLOBE NEWSWIRE) -- MasterBeef Group (the “Company”), a full-service restaurant group in Hong Kong, specializing in Taiwanese hotpot and Taiwanese barbecue, today announced today that it has issued an additional 155,000 ordinary shares (the "Ordinary Shares") at a price of US$4.00 per share for gross proceeds of approximately $620,000, before deducting underwriter discounts and other related expenses, pursuant to the partial exercise of the underwriter's over-allotment option in conn ...

Group 1 - The Company, Columbus Circle Capital Corp I, has announced the pricing of its upsized initial public offering (IPO) of 22,000,000 units at a price of $10.00 per unit, with trading expected to begin on May 16, 2025 [1] - Each unit consists of one Class A ordinary share and one-half of one redeemable warrant, with each whole warrant allowing the purchase of one Class A ordinary share at a price of $11.50 per share [1] - The Company has granted underwriters a 45-day option to purchase an additional 3,300,000 units at the IPO price to cover over-allotments [1] Group 2 - The Company is a blank check company formed to effect a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses [2] - The management team is led by Gary Quin as CEO and Chairman, and Joseph W. Pooler, Jr. as CFO, with independent directors including Garrett Curran, Alberto Alsina Gonzalez, Dr. Adam Back, and Matthew Murphy [2] Group 3 - Cohen & Company Capital Markets acted as the lead book-running manager for the offering, with Clear Street LLC as joint book-runner [3] - Legal counsel for the Company includes Ellenoff Grossman & Schole LLP and Ogier (Cayman) LLP, while Loeb & Loeb LLP served as legal counsel to the underwriters [3] Group 4 - A registration statement for the units and underlying securities was declared effective by the Securities and Exchange Commission on May 15, 2025 [4]

Company Overview - eToro has priced its IPO at $52 per share, raising nearly $310 million and valuing the company at approximately $4.2 billion [1] - Founded in 2007 by brothers Yoni and Ronen Assia along with David Ring, eToro competes with platforms like Robinhood and generates revenue through trading fees and non-trading activities [5] Financial Performance - eToro's net income surged almost thirteenfold to $192.4 million in the last year, up from $15.3 million the previous year [6] - Revenue from cryptoassets more than tripled to over $12 million in 2024, with one-quarter of its net trading contribution coming from crypto, an increase from 10% the prior year [6] IPO Context - The IPO market is showing signs of recovery, with eToro's Nasdaq debut under the ticker symbol ETOR being a potential indicator of market readiness for risk [4] - eToro previously attempted to go public in 2022 through a SPAC merger, which was scrapped due to a downturn in equity markets [7] Investor Interest - BlackRock has expressed interest in purchasing $100 million in shares at the IPO price, with the company planning to sell 5 million shares in the offering, alongside existing investors selling another 5 million [8]

Company Overview - OMS Energy Technologies Inc. is a growth-oriented manufacturer specializing in surface wellhead systems and oil country tubular goods for the oil and gas industry [6] - The company serves both onshore and offshore exploration and production operators across six vital jurisdictions in the Asia Pacific, Middle Eastern, and North African regions [6] - OMS operates 11 strategically located manufacturing facilities to ensure rapid response times and customized technical solutions [6] Initial Public Offering (IPO) Details - OMS announced the pricing of its initial public offering of 3,703,704 ordinary shares at a public offering price of US$9.00 per share, totaling US$33.3 million [1] - The ordinary shares are expected to begin trading on the Nasdaq Capital Market under the ticker symbol "OMSE" on May 13, 2025, with the offering expected to close on May 14, 2025 [2] - The underwriter has a 45-day option to purchase up to 555,555 additional ordinary shares at the public offering price [2] Financial Advisory and Regulatory Information - Roth Capital Partners acted as the sole manager for the offering, while Joseph Gunnar & Co., LLC served as the financial advisor [3] - A registration statement related to the securities has been filed with the U.S. Securities and Exchange Commission and was declared effective on April 28, 2025 [3]

Core Viewpoint - Apimeds Pharmaceuticals US, Inc. has successfully completed its initial public offering, raising $13.5 million to fund clinical trials and other operational needs [1][3]. Group 1: Initial Public Offering Details - The company closed its initial public offering of 3,375,000 shares at a price of $4.00 per share, with trading commencing on May 9, 2025 [1]. - Gross proceeds from the offering amounted to $13.5 million before expenses [1]. - Underwriters were granted a 45-day option to purchase an additional 506,250 shares at the public offering price [1]. Group 2: Use of Proceeds - The net proceeds from the offering are intended to fund a Phase III clinical trial for knee osteoarthritis [3]. - The company plans to initiate at least one non-registered corporate sponsorship study in multiple sclerosis [3]. - Proceeds will also be allocated for manufacturing its product candidate and general working capital needs [3]. Group 3: Company Overview - Apimeds is a clinical stage biopharmaceutical company developing Apitox, a bee venom-based toxin with potential therapeutic effects [6]. - The product is being developed as a treatment for knee pain in osteoarthritis patients who do not respond adequately to conventional therapies [6].

Company Overview - Perimeter Acquisition Corp. I is a special purpose acquisition company targeting companies in the defense and national security sectors, leveraging its management's extensive investment and operational experience [5] - The company also aims to explore opportunities at the intersection of defense, technology, and national security, believing its management team can drive value creation post-business combination [5] Initial Public Offering (IPO) Details - The company announced the pricing of its upsized initial public offering of 21,000,000 units at $10.00 per unit, with units expected to trade on Nasdaq under the ticker symbol "PMTRU" starting May 13, 2025 [1] - The offering is anticipated to close on May 14, 2025, subject to customary closing conditions, with Citigroup Global Markets Inc. serving as the sole book-running manager [2] - An additional 3,150,000 units may be purchased by the underwriter to cover over-allotments [2] Regulatory and Compliance Information - A registration statement on Form S-1 related to these securities has been filed with the SEC and was declared effective on May 12, 2025, with the offering being made only by means of a prospectus [3]

Hopewell, New Jersey, May 08, 2025 (GLOBE NEWSWIRE) -- Apimeds Pharmaceuticals US, Inc. (NYSE American: APUS) (“Apimeds” or the “Company”), a clinical stage biopharmaceutical company that is in the process of developing Apitox, an intradermally administered bee venom-based toxin which potentially exhibits diverse therapeutic effects, today announced the pricing of its initial public offering of 3,375,000 shares of common stock at a price of $4.00 per share. The gross proceeds to Apimeds from the offering, b ...

NEW YORK, May 08, 2025 (GLOBE NEWSWIRE) -- Dune Acquisition Corporation II (the “Company”) announced today the closing of its initial public offering of 14,375,000 units, including the exercise in full of the underwriters’ over-allotment option. The offering was priced at $10.00 per unit, resulting in gross proceeds of $143,750,000. The units are listed on the Nasdaq Global Market (the “Nasdaq”) and commenced trading under the ticker symbol “IPODU” on May 7, 2025. Each unit consists of one Class A ordinary ...